Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Ebner Jakob |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Manninger, M; Ebner, J; Zweiker, D; Sieghartsleitner, R; Mastnak, B; Bisping, E; Lercher, P; Riedlbauer, R; Rotman, B; Brussee, H; Scherr, D
Is there a difference in outcome in patients undergoing first vs. second line ablation of atrial fibrillation?
EUR HEART J. 2018; 39: 1418-1418.-European-Society-of-Cardiology Congress; AUG 25-29, 2018; Munich, GERMANY.
[Poster]
Web of Science
Ebner, J; Manninger, M; Sieghartsleitner, R; Zweiker, D; Mastnak, B; Bisping, E; Lercher, P; Riedlbauer, R; Rotmann, B; Brussee, H; Scherr, D
Is there a difference in outcome in patients undergoing first vs. second line ablation of atrial fibrillation?
WIEN KLIN WOCHENSCHR. 2017; 129 (Suppl 1): S42. 2017; -ÖKG Jahrestagung; JUN 7-10, 2017; Salzburg, AUSTRIA.
[Poster]
FullText
Manninger, M; Zweiker, D; Ebner, J; Sieghartsleitner, R; Ohnewein, B; Brussee, H; Scherr, D
Is there a difference in outcome in patients undergoing first vs. second line ablation of atrial fibrillation? (P913)
Europace (2017) 19 (suppl_3): iii180. 2017; -EHRA Europace 2017; JUN 18-21, 2017; Vienna, AUSTRIA.
[Poster]
Zweiker, D; Manninger, M; Ebner, J; Sieghartsleitner, R; Ohnewein, B; Bisping, E; Lercher, P; Prenner, G; Riedlbauer, R; Brussee, H; Scherr, D
Impact of non-VKA oral anticoagulants on AF ablation outcome
WIEN KLIN WOCHENSCHR. 2017; 129 (Suppl 1): S41. 2017; -ÖKG Jahrestagung; JUN 7-10, 2017; Salzburg, AUSTRIA.
[Poster]
Zweiker, D; Manninger, M; Ebner, J; Sieghartsleitner, R; Ohnewein, B; Brussee, H; Scherr, D
Impact of non-VKA oral anticoagulants on AF ablation outcome
Europace (2017) 19 (suppl_3): iii69. 2017; -EHRA Europace 2017; JUN 18-21, 2017; Vienna, AUSTRIA.
[Poster]
FullText
Ebner, J; Manninger, M; Zweiker, D; Mastnak, B; Bisping, E; Lercher, P; Riedlbauer, R; Rotman, B; Brussee, H; Scherr, D
Is there a difference in outcome in patients undergoing ablation of paroxysmal atrial fibrillation as 1st vs 2nd line treatment?
WIEN KLIN WOCHENSCHR. 2016; 128: S295-S296.
[Oral Communication]
Web of Science
Manninger, M; Zweiker, D; Herbst, V; Thon-Gutschi, E; Zirngast, B; Huber, S; Ebner, J; Pieske, BM; Brussee, H; Schotten, U; Heinzel, FR; Post, H; Scherr, D
Increased arrhythmia stability is associated with risk-factor specific structural remodelling in a porcine model of arterial hypertension and atrial fibrillation
WIEN KLIN WOCHENSCHR. 2016; 128: S252-S253.
[Poster]
Web of Science
Scherr, D; Klein, A; Calkins, H; Bertaglia, E; Grebmer, C; Deisenhofer, I; Miyazaki, S; Iesaka, Y; Manninger, M; Ebner, J; Marine, JE
Incidence and predictors of LA thrombus prior to catheter ablation of atrial fibrillation: A multicenter study
EUR HEART J. 2016; 37: 1035-1035.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY.
[Poster]
Web of Science
Scherr, D; Yarmohammadi, H; Klein, A; Calkins, H; Bertaglia, E; Grebmer, C; Deisenhofer, I; Miyasaki, S; Iesaka, Y; Manninger, M; Ebner, J; Marine, J
Incidence and Predictors of LA Thrombus Prior to Catheter Ablation of Atrial Fibrillation: A Multicenter Study
J CARDIOVASC ELECTR. 2016; 27(5):645-646.-Boston AF Symposium (AFIB); JAN 14-16, 2016; Orlando, FL.
[Poster]
Web of Science